Lobbying client · LD-2 disclosures
Novartis Pharmaceuticals Pty Ltd ( Australia)
Australia
4 filings from 1 registrant · 2014–2015 · latest filed Jul 30, 2015
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Copyright/Patent/Trademark
CPT
3 filings
Health Issues
HCR
3 filings
Pharmacy
PHA
3 filings
Who did the lobbying
Every lobbyist named on this client's filings.
- Nicholas Campbell Capitalhill Advisory4 filingsthrough 2015
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: novartis-pharmaceuticals-pty-ltd-australia.